[Stimulation of the microsomal enzyme system as a therapeutic principle in the newborn infant].
D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000139:chemically induced / Q000151:congenital; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D006801:Humans; D006933:Hyperbilirubinemia, Hereditary; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy* / Q000201:enzymology; D007567:Jaundice, Neonatal / Q000517:prevention & control; D008431:Maternal-Fetal Exchange; D008862:Microsomes, Liver / Q000201:enzymology*; D010101:Oxygen Consumption; D010634:Phenobarbital / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D011164:Porphyrias / Q000139:chemically induced; D011247:Pregnancy
D000927:Anticonvulsants; D010634:Phenobarbital
Die Stimulierung des mikrosomalen Enzymsystems als therapeutisches Prinzip im Neugeborenenalter